Lepidico Limited
Lepidico Limited (LPD.AX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Lepidico Limited (LPD.AX), covering cash flow, earnings, and balance sheets.
Lepidico Limited (LPD.AX) Income Statement & Financial Overview
View the income breakdown for Lepidico Limited LPD.AX across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $305414.00 | $304970.00 | $288644.00 | $282681.00 |
| Gross Profit | -$305414.00 | -$304970.00 | -$288644.00 | -$282681.00 |
| Gross Profit Ratio | $0.00 | $0.00 | ||
| R&D Expenses | $0.00 | $0.00 | $0.00 | $56901.00 |
| SG&A Expenses | $2327.00 | $3492.00 | $4.47M | $4.20M |
| Operating Expenses | $2327.00 | $3492.00 | $4.47M | $4.26M |
| Total Costs & Expenses | $2327.00 | $3492.00 | $4.76M | $4.54M |
| Interest Income | $0.00 | $125907.00 | $197986.00 | $76388.00 |
| Interest Expense | $0.00 | $339817.00 | $319138.00 | $313158.00 |
| Depreciation & Amortization | $305414.00 | $305.00 | $288644.00 | $282681.00 |
| EBITDA | -$3.36M | -$3.53M | -$4.32M | -$4.26M |
| EBITDA Ratio | $0.00 | $0.00 | ||
| Operating Income | -$2327.00 | -$3492.00 | -$4.76M | -$4.54M |
| Operating Income Ratio | $0.00 | $0.00 | ||
| Other Income/Expenses (Net) | -$4.001M | -$680586.00 | -$167310.00 | $6.51M |
| Income Before Tax | -$4.003M | -$4172.00 | -$4.93M | $1.97M |
| Income Before Tax Ratio | $0.00 | $0.00 | ||
| Income Tax Expense | -$624264.00 | $483.00 | -$1.13M | $1.78M |
| Net Income | -$2751.00 | -$3689.00 | -$3.80M | $192916.00 |
| Net Income Ratio | $0.00 | $0.00 | ||
| EPS | $0.00 | -$0.001 | -$0.001 | $0.00 |
| Diluted EPS | $0.00 | -$0.001 | -$0.001 | $0.00 |
| Weighted Avg Shares Outstanding | $7.86B | $7.69B | $8.04B | $8.04B |
| Weighted Avg Shares Outstanding (Diluted) | $7.86B | $7.69B | $8.04B | $8.04B |
Over the past four quarters, Lepidico Limited demonstrated steady revenue growth, increasing from $0.00 in Q2 2023 to $0.00 in Q4 2024. Operating income reached -$2327.00 in Q4 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$3.36M, reflecting operational efficiency. Net income rose to -$2751.00, with EPS at $0.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan